Home › Lung Cancer › Massachusetts › Newton
Lung Cancer clinical trials in Newton, MA
3 studies for Lung Cancer are looking for participants at sites in and around Newton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Dana-Farber Cancer Institute at Boston Medical Center - Brighton, Brighton · 3 mi away
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RecruitingPhase 3
- Dana-Farber Cancer Institute at Boston Medical Center - Brighton, Brighton · 3 mi away
EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations
RecruitingHealthy volunteers welcome
- Dana-Farber Cancer Institute at Steward St. Elizabeth's, Brighton · 3 mi away
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Washington, DC41 studies
- Chicago, IL41 studies
- Nashville, TN40 studies
- Arlington, VA40 studies
- Baltimore, MD40 studies
- St. Louis, MO39 studies
- Columbus, OH36 studies
- Philadelphia, PA36 studies
Other studies in Newton
- Alzheimer's Disease12 studies
- Obesity10 studies
- Major Depressive Disorder9 studies
- Psoriasis6 studies
- Depression6 studies
- Overweight6 studies
- Non-Small Cell Lung Cancer5 studies
- Cancer (all types)4 studies
- Atopic Dermatitis (Eczema)4 studies
- Breast Cancer4 studies
- Ulcerative Colitis4 studies
- Schizophrenia4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.